Nelson Labs announced the announced the expansion of its laboratory space at its Wiesbaden, Germany facility. The Wiesbaden facility offers customers end-to-end sterility assurance services with Nelson Labs testing and Sterigenics sterilization in one location. This strategic investment reinforces Nelson Labs’ commitment to Safeguarding Global Health® by enhancing its capabilities in packaging validation and microbiological testing for medical device and pharmaceutical customers.
The expansion includes four new laboratories to address the significantly increased packaging testing services demand in the market. These additional capabilities enhance current microbiological testing capacity including endotoxin, bioburden, EtO residual testing, and BI sterility. In addition to this capacity enhancement, this expansion enables the introduction of packaging integrity services.
The new facility will conduct a full suite of packaging testing services in compliance with global regulatory standards, including:
• Strength Testing
• Integrity Testing
• Container Closure Integrity Testing
• Microbial Barrier Testing
• Aging Studies
• Distribution Testing
The facility expansion also includes improvements to bioburden testing, featuring separate sample, personnel entry points and HEPA-filtered air systems to ensure the highest standards of contamination control.
Nelson Labs plans to have the full scope of testing services operational by the end of 2025 with ISO 17025 accreditation scope expanded to add the new packaging testing for early 2026.
The Wiesbaden facility remains fully operational throughout the expansion, ensuring uninterrupted support for all current and future testing and sterilization needs.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!